Dr. Karen L. Chapman, MD

Dr. Chapman practices at Karen L. Chapman, MD, FACS in Sarasota, Florida.

Dr. Chapman's NPI, 1275534182, was assigned on August 2, 2005. Dr. Chapman graduated from UVA School of Medicine in 1990. Dr. Chapman holds Florida license ME73371.

Dr. Chapman's primary practice is Karen L. Chapman, MD, FACS, at 1750 S Osprey Ave, Sarasota, FL 34239-3511. The practice phone is (941) 953-5800.

Dr. Chapman's primary practice is Karen L. Chapman, MD, FACS in Sarasota, Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chapman practices. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Chapman's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Chapman is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chapman's licenses on file in 5 states: Florida, Texas, Virginia, Colorado and Minnesota.

Dmand AI lists conjunctivitis, eye infection or inflammation, eyelid inflammation and vision problems among the conditions Dr. Chapman treats.

CMS data shows 7,086 Medicare services from Dr. Chapman across 13 procedure codes in 2024, for 418 Medicare patients. Medicare paid $130,865 for them. Every service was in an office.

CMS counts 418 Medicare patients who saw Dr. Chapman in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chapman's median patient age at 77, with 58% women.

In 2024, Dr. Chapman wrote 356 Medicare Part D claims for 168 patients. 86% of them were for generic drugs. CMS names the drug for 308 of them, across 8 drugs with 11 or more claims each, at $3,442 in total drug cost. In 2023, CMS named 289 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Chapman for performance year 2024, reported individually. Dr. Chapman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of melanoma (skin cancer) excision by Dr. Chapman, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Chapman.

CMS Open Payments shows 34 general payments to Dr. Chapman from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Musculoskeletal Transplant Foundation Inc. paid the most, $829.

Dmand AI lists 2 awards for Dr. Chapman.

Dr. Chapman graduated from UVA School of Medicine in 1990. Dr. Chapman is a member of AAO and ACS.

Dr. Chapman is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.